TASL-TSOC Taiwan Position Statement for the Management of Metabolic Dysfunction-Associated Fatty Liver Disease and Cardiovascular Diseases
Clin Mol Hepatol. 2023 Oct 4. doi: 10.3350/cmh.2023.0315. Online ahead of print.ABSTRACTMetabolic dysfunction associated fatty liver disease (MAFLD) is an increasingly important and common liver disease worldwide. The diagnosis of MAFLD is based on the presence of steatosis on image/histology/serum markers accompanied with presence of at least one of the three metabolic features that include overweight/obesity, type II diabetes mellitus, and metabolic risk factors. MAFLD is not only a liver disease but also a contributing or related factor of cardiovascular diseases (CVD) which lead to the major etiology of morbidity and m...
Source: Clinical and molecular hepatology - October 4, 2023 Category: Gastroenterology Authors: Pin-Nan Cheng Wen-Jone Chen Charles Jia-Yin Hou Chih-Lin Lin Ming-Ling Chang Chia-Chi Wang Wei-Ting Chang Chao-Yung Wang Chun-Yen Lin Chung-Lieh Hung Cheng-Yuan Peng Ming-Lung Yu Ting-Hsing Chao Jee-Fu Huang Yi-Hsiang Huang Chi-Yi Chen Chern-En Chiang Han Source Type: research
Adding to the confusion in more than name
Clin Mol Hepatol. 2023 Sep 18. doi: 10.3350/cmh.2023.0367. Online ahead of print.NO ABSTRACTPMID:37718551 | DOI:10.3350/cmh.2023.0367 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - September 18, 2023 Category: Gastroenterology Authors: Jacob George Source Type: research
From NASH, MAFLD, to SLD: updates of nomenclature and impact on clinical trials
Clin Mol Hepatol. 2023 Sep 18. doi: 10.3350/cmh.2023.0359. Online ahead of print.NO ABSTRACTPMID:37718552 | DOI:10.3350/cmh.2023.0359 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - September 18, 2023 Category: Gastroenterology Authors: Ming-Lun Yeh Ming-Lung Yu Source Type: research
Correspondence on Letter regarding "Risk factors in nonalcoholic fatty liver disease"
Clin Mol Hepatol. 2023 Aug 29. doi: 10.3350/cmh.2023.0310. Online ahead of print.NO ABSTRACTPMID:37718595 | DOI:10.3350/cmh.2023.0310 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - September 18, 2023 Category: Gastroenterology Authors: Eileen L Yoon Dae Won Jun Source Type: research
Adding to the confusion in more than name
Clin Mol Hepatol. 2023 Sep 18. doi: 10.3350/cmh.2023.0367. Online ahead of print.NO ABSTRACTPMID:37718551 | DOI:10.3350/cmh.2023.0367 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - September 18, 2023 Category: Gastroenterology Authors: Jacob George Source Type: research
From NASH, MAFLD, to SLD: updates of nomenclature and impact on clinical trials
Clin Mol Hepatol. 2023 Sep 18. doi: 10.3350/cmh.2023.0359. Online ahead of print.NO ABSTRACTPMID:37718552 | DOI:10.3350/cmh.2023.0359 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - September 18, 2023 Category: Gastroenterology Authors: Ming-Lun Yeh Ming-Lung Yu Source Type: research
Correspondence on Letter regarding "Risk factors in nonalcoholic fatty liver disease"
Clin Mol Hepatol. 2023 Aug 29. doi: 10.3350/cmh.2023.0310. Online ahead of print.NO ABSTRACTPMID:37718595 | DOI:10.3350/cmh.2023.0310 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - September 18, 2023 Category: Gastroenterology Authors: Eileen L Yoon Dae Won Jun Source Type: research
Adding to the confusion in more than name
Clin Mol Hepatol. 2023 Sep 18. doi: 10.3350/cmh.2023.0367. Online ahead of print.NO ABSTRACTPMID:37718551 | DOI:10.3350/cmh.2023.0367 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - September 18, 2023 Category: Gastroenterology Authors: Jacob George Source Type: research
From NASH, MAFLD, to SLD: updates of nomenclature and impact on clinical trials
Clin Mol Hepatol. 2023 Sep 18. doi: 10.3350/cmh.2023.0359. Online ahead of print.NO ABSTRACTPMID:37718552 | DOI:10.3350/cmh.2023.0359 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - September 18, 2023 Category: Gastroenterology Authors: Ming-Lun Yeh Ming-Lung Yu Source Type: research
Correspondence on Letter regarding "Risk factors in nonalcoholic fatty liver disease"
Clin Mol Hepatol. 2023 Aug 29. doi: 10.3350/cmh.2023.0310. Online ahead of print.NO ABSTRACTPMID:37718595 | DOI:10.3350/cmh.2023.0310 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - September 18, 2023 Category: Gastroenterology Authors: Eileen L Yoon Dae Won Jun Source Type: research
